Frontida BioPharm is a contract development and manufacturing organization focused on supplying oral pharmaceuticals for cardiovascular, gastrointestinal, endocrine, CNS conditions and infectious diseases. Its Duragran process technology allows creating controlled release beadlets and granules of uniform and narrow particle size range. The company also offers AdaptDose technology platform.
|Employees (est.) (Mar 2020)||110|
Frontida BioPharm latest funding size
When was Frontida BioPharm founded?
Frontida BioPharm was founded in 2016.
How many employees does Frontida BioPharm have?
Frontida BioPharm has 110 employees.
Who are Frontida BioPharm competitors?
Competitors of Frontida BioPharm include Kymos Pharma Services, ABL and Amylgen.
Receive alerts for 300+ data fields across thousands of companies